[Seite 71↓]


  1. Aboud E. Adult granulosa cell tumours of the ovary. Eur J Gynecol Oncol 1997;18:520-2.

  2. Abu-Yousef M. Case 5: gynecological. Granulosa cell tumor of the ovary with endometrial carcinoma. Journal of Ultrasound in Medicine 2000;19:357.

  3. Al-Badawi I.A., Basher P.M.A., Ghatage P., Nation J.G., Schepanski A., and Stuart G.C.E. Postoperative chemotherapy in advanced ovarian granulosa cell tumors. Int J Gynecol Cancer 12, 119-123. 2002.

  4. Ala-Fossi SL, .Maenpaa J, Aine R, Koivisto P, Koivisto AM., Punnonen R . Prognostic significance of p53 expression in ovarian granulosa cell tumors. Gynecol Oncol 1997;66:475-9.

  5. Alberti W., Bamberg M., Schulz U. Granulosazelltumoren. Dtsch med Wschr 1984;109:750-2.

  6. Anderson W.R., Levine A.J., MacMillan D. Granulosa-theca cell tumors: clinical and pathologic study. Am J Obstet Gynecol 1971;110:32-5.

  7. Anikuwe C., Dawood M.Y., Kramer E. Granulosa and theca cell tumors. Obstet Gynecol 1978;51 :214-20.

  8. Arora D.S., Cooke I.E., Ganesan T.S., Ramsdale J., Manek S., Charnock F.M.L. et al. Immnunohistochemical expression of inhibin/activin subunits in epithelial and granulosa cell tumours of the ovary . J Path 1997;181:413-8.

  9. Asschenfeldt P., Thind P. Granulosa cell tumor. A case with primary peritoneal carcinoses and recurrence after 24 years. Ugaeskr Laeger 1984;146: 1938.

  10. Barlow J.J., Piver M.S., Chuang J.T., Cortes E.P., Ohnuma T., Holland J.F . Adriamycin and bleomycin, alone and in combination, in gynecologic cancers. Cancer 1973;32:735-43.

  11. Betta P., Bellingeri D. Androgenic juvenile granulosa cell tumor.Case report. Eur J Gynecol Oncol 1985 ;6:71-4.

  12. Björkholm E. Granulosa-cell and theca-cell tumor. The clinical picture and long term out-come for the Radiumhemmet series. Acta Obstet Gynecol Scand 1980;59:361.

  13. Björkholm E. Granulosa cell tumor: A comparison of survival in patients and matched controls. Am J Obstet Gynecol 1980;138:329-31.

  14. Björkholm E., Silferswärd C. Prognostic factors in granulosa cell tumors. Gynecol Oncol 1981;11:261-74.

  15. Boggess J.F., Soules M.R., Goff B.A., Greer B.E., Cain J.M., Tamimi H.K . Serum inhibin an disease status in woman with ovarian granulosa cell tumor. Gynecol Oncol 1997;64:64-9.

  16. Bühl A., Zöfel P. SPSS Version 8 Einführung in die moderne Datenanalyse unter Windows, Bonn: Addison-Wesley-Longman, 1999.

  17. Burger H.G., Bailie A., Drummond A.E., Healy D.L., Jobling T., Mamers P. et al . Inhibin and ovarian cancer. J Reproductive Immunology 1998 ;39:77-87.

  18. Burger H.G., Robertson D.M., Cahir N., Mamers P., Healy D.L., Jobling T. et al . Charakterization of inhibin immunoreactivity in post-menopausal women with ovarian tumours. Clinical Endocrinology 1996 ; 44 : 413-8.

  19. Busby T., Anderson G.W. Feminzing mesenchymomas of the ovary. Am J Obstet Gynecol 1954;68:1391-420.

  20. [Seite 72↓]

    Calaminus G, Wessalowski R., Harms D., Gobel U. Juvenile granulosa cell tumors of the ovary in children and adolescents: results from 33 patients registered in a prospective cooperative study. Gynecol Oncol 1997; 65:447-52.

  21. Camlibel F.T., Caputo T.A. Chemotherapie of granulosa cell tumors. Am J Obstet Gynecol 1983;145:763-5.

  22. Castro C.V., Malpica A., Hearne R.H., Silva E.G. Androgenic adult granulosa cell tumor in a 13-year-old prepubertal patient: a case report and review of the literature. Int J Gynecol Pathol 2000;19:266-71.

  23. Choi YL., Kim HS., Ahn G. Immunoexpression of inhibin alpha subunit, inhibin/activin betaA subunit and CD99 in ovarian tumors. Arch Pathol Lab Med 2000; 124:563-9.

  24. Colombo N. Management of sex cord-stromal tumors. Gershenson D.M. Ovarian Cancer, 1 ed. 1999:417.

  25. Colombo N., Sessa C., Landoni F, Sartori E., Pecorelli S., Mangioni C. Cisplatin, vinblastin, and bleomycin combination chemotherapy in metastatic granulosa cell tumor of the ovary. Obstet Gynecol 1986;67:265-8.

  26. Cooke I.E., O`Brien M., Charnock F.M., Groome N.P., Ganesan T.S. Inhibin as a marker for ovarian cancer. British Journal of Cancer 1995;71:1046-50.

  27. Coppes M.J., Ye.Y, Rackley R., Zhao X.-I., Liefers G.J., Casey G. et al. Analysis of WT1 in granulosa cell and other cord-stromal tumors. Cancer Research 1993;53:2712-4.

  28. Cronje H.S., Niemand I., Bam R.H., Woodruff J.D . Review of the granulosa-theca cell tumors from the emil Novak ovarian tumor registry. Am J Obstet Gynecol 1999;180:323-7.

  29. Cronje HS., Niemand I, .Bam RH, Woodruff JD . Granulosa and theca cell tumors in children: a report of 17 cases and literature review. Obstetrical & Gynecological Survey 1998;53:240-7.

  30. Cutler S.J., Ederer F. Maximum utilization of the life table method in analyzing survival. J.Chronic Dis . 1958;8:699-712.

  31. Dawson Saunders B., Trapp R.G. Basic and clinical biostatistics. Appleton and Lange, 1990. 199-206.

  32. Drescher F.S, Sehouli J., Buchmann E., Ricke E., Weidemann H., and Lichtenegger W. Das Rezidiv eines Granulosazelltumors - ein multiviszerales Problem ! Kongressband Tagung der Norddeutschen Gesellschaft für Gynäkologie und Geburtshilfe, 1999. 184-185.

  33. Dubrauzky V. Zur Therapie der follikelhormonbildenen Ovarialtumoren. Krebsarzt 1958;13:136.

  34. Engle E.B. Roentgen treatment of granulosa cell carcinoma of the ovary. Amer J Roentgenol 1958;80:793.

  35. Evans A.T., Gaffey T.A., Malkasian G.D, Annegers J.F. Clinicopathological review of 118 granulosa and 82 theca cell tumors. Obstet Gynecol 1980;55:231-8.

  36. Evans M.P., Webb M.J., Gaffey T.A., Katzmann J.A., Suman V.J., Hu T.C. DNA ploidy of ovarian granulosa cell tumors and outcome in 40 patients. Cancer 1995;75:2295-8.

  37. Farias-Eisner R.P., Berek J.S. Ovarian cancer. Casciato D.A., Lowitz B.B . Manual of Clinical Oncology, 4 ed. Lippincott Williams & Williams, 2000:255-68.

  38. Fathalla M.F. The role of ovarian stroma in the hormone production by ovarian tumors. J Obstet Gynaecol Br Commonw 1967;75:279.

  39. Fervers B., Kebrat P., Guastalla J.P., Dauplat J., Thomas L., Basuyau J.P. et al. Standards, options and recommendations: Clinical practice guidelines for diagnosis, treatment and follow-up in epithelial ovarian cancer. An Oncol 2000;11:84.

  40. [Seite 73↓]

    Fox H., Langly F.A. A clinicopathological study of 92 cases of granulosa cell tumors of the ovary with special reference to factors influencing prognosis. Cancer 1975;35:231-41.

  41. Furger C., Fiddes R.J., Quinn D.I., Bova R.J., Daly R.J., Sutherland R.L. Granulosa cell tumors express erbB4 and are sensitive to the cytotoxic action of heregulin-ß2/PE40. Cancer Research 1998;58:1773-8.

  42. Gee D.C., Russel P . The pathological asessment of ovarian neoplasms. IV: The sex cord stromal tumors. Pathology 1981;13: 235-55.

  43. Gershenson D.M., Copeland L.J., Kavanagh J.J., Stringer A.C., Saul P.B., Wharton J.T. Treatment of metastatic stromal tumors of the ovary with cisplatin, doxorubicin, and cyclophosphamide. Gynecol Oncol 1987;70:765-9.

  44. Goldston W.R., Johnston W.W., Fetter B.F., Parker R.T:, Wilbanks G.D. Clinicopathologic studies in feminizing tumors of the ovary. Am J Obstet Gynecol 1972;112:422-9.

  45. Guintoli R.L., Celebre J.A., Wu C.H., Wheeler J.E., Mikuta J.J . Androgenic function of a granulosa cell tumor. Obstet Gynecol 1976;47:77.

  46. Gusberg S.B., Kardon P. Proliferative endometrial response to theca-granulosa cell tumors . Am J Obstet Gynecol 1967;111:633.

  47. Haba R., Miki H., Kobayashi S., Ohmori M. Combined analysis of flow cytometry and morphometry of ovarian granulosa cell tumor. Cancer 1993;72:3258-62.

  48. Healy D.L., Burger H.G., Mamers P., Jobling T., Bangah M., Quinn M. et al. Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. New England Journal of Medicine 1993;329:1539-42.

  49. Hines J.F., Mahmoud A.K. Recurrent granulosa cell tumor of the ovary 37 years after inital diagnosis: A case report and review of the literature. Gynecol Oncol 1995;60:484-8.

  50. Hitchcock C.L., Norris H.J., Khalifa M.A., Wargotz E.S . Flow cytometric analysis of granulosa cell tumors . Cancer 1989;46:2127-32.

  51. Homesley H.D., Bundy B.N., Hurteau J.A., and Roth L.M. Bleomycin, etoposide, and cisplatin combination therapy of ovarian granulosa cell tumos and other stromal malignancies: a gynecologic oncology group study. Gynecol Oncol 72, 131-137. 1999.

  52. Ituarzeta N., Kenny F.M., Sieber W. Precocious pseudopuberty due to granulosa cell tumor in three girls. Am J Dis Child 1967;114:39.

  53. Jacobs I., R.C.Bast. The CA-125 tumor-associated antigen: A review of the literature. Human Reproduction 1989 ;4:1-12.

  54. Jarabak J., Talerman A. Virilization due to a metastasizing granulosa cell tumor. Int J Gynecol Pathol 1983;2:316-24.

  55. Jobling T., Mamers P., Healy D.L., MacLachlan V., Burger H.G., Quinn M. et al . A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol Oncol 1994;55:285-9.

  56. Johnston W.W., Goldston W.R., Montgomery M.S . Clinicopathologic studies in feminizing tumors of the ovary. III. The role of genital cytology. Acta Cytol 1971;15:334.

  57. Kaesemann H., Caffier H., Hoffman F.J., Crombach G., Würz H., Kreienberg R. et al. Monoklonale Antikörper in Diagnostik und Verlaufskontrolle des Ovarialkarzinoms. CA 125 als Tumormarker. Klinische Wochenschrift 1986;64:781-5.

  58. Kalavathi N. Granulosa cell tumour - hormonell aspects and radiosensitivity. Clin Radiol 1976;22:524.

  59. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Statist Assoc 1958;53:457-81.

  60. Kaye S.B., Davies E. Cyclophosphamide adriamycin and cis-platin for the treatment of advanced granulosa cell tumor, using serum estradiol as a tumor marker. Gynecol Oncol 1984;24:261-4.

  61. [Seite 74↓]

    Kietlinska Z., Pietrzak K., Drabik M. The management of granulosa cell tumors of the ovary based on long term follow up. Eur J Gynecol Oncol 1993;14:118-27.

  62. Klemi P.J., Joensuu H., Salmi T. Prognostic value of flow cytometrie DNA content analysis in granulosa cell tumor of the ovary. Cancer 1990;65:1193.

  63. Kuhn W. Maligne Ovarialtumoren. Deutsche Krebsgesellschaft, Informationszentrum für Standards in der Onkologie . 2001.

  64. Lappöhn R.E., Burger H.G., Bouma J., Bangah M., Krans M . Inhibin as a marker for granulosa cell tumor. Acta Obstet Gynecol Scand 1989;155:61-5.

  65. Lauszus F.F., Petersen A.C., Greisen J, Jakobsen A . Granulosa cell tumor of the ovary: a population -based study of 37 women with stage I disease. Gynecol Oncol 2001;81:456-60.

  66. Lee I-W., Levin W., Chapman W., Goldberg R.E.A., Murphy K.J., Milosevic M. Radiotherapy for the treatment of metastatic granulosa cell tumor in the mediastinum: a case report. Gynecol Oncol 1999;73:455-60.

  67. Li M.K., van der Walt J.D. Recurrent granulosa cell tumor of the ovary 22 years after primary excision. J R Coll Surg Edinb 1984;29:192-4.

  68. Lusch C.L., Mercurio T.M., Runyeon W.K. Delayed recurrence and chemotherapy of a granulosa cell tumor. Obstet Gynecol 1978;51:505-7.

  69. Malkasian G.D., Webb M.K., Jorgenson E.O. Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas. Obstet Gynecol 1974;44:885-8.

  70. Malmström H., Hogberg T., Risberg B., Simonsen E . Granulosa cell tumors of the ovary: prognostic factors and outcome. Gynecol Oncol 1994;52:50-5.

  71. Margolin K., Pak H.Y., Esensten M.L., Doroshow J.H. Hepatic metastasis in granulosa cell tumor of the ovary. Cancer 1985;56:691-5.

  72. Martikainem H., Penttinem J, Huhtaniemi I, Kauppila A. Gonadotropin-releasing hormone agonist analog therapy effective in ovarian granulosa cell malignancy. Gynecol Oncol 1989;35:406.

  73. Matzuk M.M., Finegold M.J., Su J.J., Hsueh A.J.W., Bradeley A. Apha inhibin is a tumor-suppressor gene with gonadal specifity in mice. Nature 1992 ; 360 : 313-9.

  74. Miller B.E., Barron B.A., Wan J.Y., Delmore J.E., Silva E.G., Gershenson D.M. Prognostic factors in adult granulosa cell tumor of the ovary. Cancer 1997;79:1951-5.

  75. Morris J.McL, Scully R.E . Endocrine pathology of the ovary. St. Louis: C.V.Mosby Co., 1958.

  76. Nakashima N., Young R.H., Scully R.E. Androgenic granulosa cell tumors of the ovary. A clinicopathological analysis of seventeen cases and review of the literature. Arch Pathol Lab Med 1984;108:786-91.

  77. Neville A.J., Kennedy W.G., Davis T.E. The chemotherapy of granulosa cell tumors of the ovary: experience of the Wisconsin Clinical Cancer Center. Med Ped Oncol 1984;12:397-400.

  78. Norris H.J., Taylor H.B. Prognosis of granulosa-theca tumors of the ovary. Cancer 1968;21:255-63.

  79. Norris H.J., Taylor H.B. Virilization associated with cystic granulosa cell tumors. Obstet Gynecol 1969;34:629.

  80. Nowak E.R., Kutchmeshgi J., Mupas R.S., Woodruff J.D. Feminizing gonadal stromal tumors . Obstet Gynecol 1971;38:701.

  81. Ohel G, Kaneti H., Schenker J.G. Granulosa cell tumors in Israel: A study of 172 cases. Gynecol Oncol 1983;15:278-86.

  82. Pal S.K., Chowdhury N.N. Late recurrence of granulosa cell tumor. Asia Oceania J Obstet Gynaecol 1986;12:21-3.

  83. [Seite 75↓]

    Pankratz E., Boyes D.A., White G.W., Galliford B.W., Fairey R.N., Benedet J.L . Granulosa cell tumors. Obstet Gynecol 1978;52:718-23.

  84. Pecorelli S., Waagenar H.C., Bonazzi G., Bokkel Huinink T., Kobierska A., Ploch E., and et al. Cisplatin (P), vinblastine (V), bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary (GCTO): An EORTC gynecological cancer cooperative group study. Proc. ASCO [Abstract 576] 7, 147 . 1988.

  85. Pecorelli S., Wagenaar H.C., Vergote I.B., Curran D., Beex L.V., Wiltshaw E. et al. Cisplatin (P), vinblastine (V) and bleomycin (B) combination chemotherapy in recurrent or advanced granulosa(-theca) cell tumours of the ovary. An EORTC Gynecological Cancer Cooperative Group study. Eur J Cancer 1999;35:1331-7.

  86. Pectasides D., Alevizakos N., Athanassiou A.E. Cisplatin-containing regimen in advanced or recurrent granulosa cell tumors of the ovary. An Oncol 1992;3:316-8.

  87. Piura B., Nemet D., Yanai-Inbar I., Cohen Y., Glezerman M. Granulosa cell tumor of the ovary: A study of 18 cases. J Surg Oncol 1994;55:71-7.

  88. Rokitansky C.V. Über Abnormalitäten des Corpus Luteum. Wien Med Ztc 1859;253-4.

  89. Savage P., Constenla D., Fisher C, Shepard J.H., Shepard D.P.J., Barton P. et al. Granulosa cell tumors of the ovary: Demographics, survival and the management of advanced disease. Clinical Oncology 1998;10:242-5.

  90. Schwartz P.E., Smith J.P. Treatment of ovarian stromal tumors. Am J Obstet Gynecol 1976;125:402-11.

  91. Schweppe K-W., Beller F.K. Clinical data on granulosa cell tumors. J Cancer Res Clin Oncol 1982;104:161-9.

  92. Scully R.E. Sex cord-mesenchyme tumours. Pathologic classification and its relation to prognosis and treatment. Gentil F. Ovarian cancer, vol. II. Heidelberg: Springer-Verlag, 1962

  93. Segal R., De Petrillo A.D., Thomas G. Clinical review of adult granulosa cell tumors of the ovary. Gynecol Oncol 1995;56:338-44.

  94. Sehouli J. First-line Chemotherapie des Ovarialkarzinoms. Sehouli J., Lichtenegger W. Chemotherapien in der Gynäkologischen Onkologie Update 2001/02. Kapitel: 2 W.Akademos Verlag, 2001:59-68..

  95. Sehouli J., Kopetsch O., Ricke J. Primary Mucinous Adenocarcinoma of the appendix: A rare entity in the differential diagnosis of ovarian cancer. J Obstet Gynaecol Res 2000;26:333-9.

  96. Serov S, Scully R.E., Sobin L.H . Histological typing of ovarian tumours . World Health Organization. International histological classification of tumours, vol. No.9. Geneva: 1973.

  97. Sharony R., Aviram R., Fishman A., Cohen I., Altaras M., Beyth Y. et al. Granulosa cell tumors of the ovary: Do they have any unique ultrasonographic and color Doppler flow features? Int J Gynecol Cancer 2001;11:229-33.

  98. Sjostedt S., Wahlen T. Prognosis of granulosa cell tumor. Acta Obstet Gynecol Scand1961;40:1.

  99. Slayton R., Johnson G., Brady L., Blessing J. Radiotherapy and chemotherapy in malignant tumors of the ovarian stroma. Proc.ASCO/AACR 1980;21:430.

  100. Slayton R.E. Management of germ cell and stromal tumors of the ovary. Semin Oncol 1984;11:299.

  101. Sommers S.C., Gates O., Goodoe I.I. A report of two cases. Obstet Gynecol 1955;6:395-8.

  102. Stage A.H., Grafton W.D. Thecomas and granulosa-theca cell tumors of the ovary. An analysis of 51 tumors. Obstet Gynecol 1977;50:27.

  103. [Seite 76↓]

    Stenwig J.T., Hazekamp J.T., Beecham J.B . A clinicopathological study of 118 cases with long term follow-up. Gynecol Oncol 1979 ;7:136-52.

  104. Tresukosol D., Kudelka A.P., Edwards C.L., Charnsangavej C., Narboni N., Kavanagh J.J. Recurrent ovarian granulosa cell tumor: a case report of dramatic response to taxol. Int J Gynecol Cancer 1995;5:156-9.

  105. Wolf J.K., Mullen J., Eifel P.J., Burke T.W., Levenback C., and Gershenson D.M. Radiation treatment of advanced or recurrent granusosa cell tumor of the ovary. Gynecol Oncol 73, 35-41. 1999.

  106. Young R.H., Dickersin G.R., Scully R.E . Juvenile granulosa cell tumors of the ovary. A clinicopathologic analysis of 125 cases. Am J Surg Pathol 1984;8: 575-96.

  107. Young R.H., Scully R.E. Sex cord-stromal, steroid cell and other ovarian tumors with endocrine, paraendorine, and neoplastic manifestations. Kurmann R.J. Blaustein, Pathology of the Female Genital Tract Chapter 19, 4 ed. Springer, 1994:783-847.

  108. Zambetti M., Escobedo A., Pilotti S.et al. Cisplatin vinblastine bleomycin combination chemotherapy in advanced or recurrent granulosa cell tumors of the ovary. Gynecol Oncol 1990;36: 317-20.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: